NCT03748420View on ClinicalTrials.gov

Medication Adherence Clinical Decision Support

NACompletedINTERVENTIONAL

Enrollment

5,421

Participants

Timeline

Start Date

August 19, 2020

Primary Completion Date

October 25, 2022

Study Completion Date

January 31, 2023

Conditions

HyperlipidemiaHypertensionDiabetesMedication Nonadherence

Interventions

OTHER

Adherence Intervention

The adherence enhanced intervention consists of clinical decision support related to cardiovascular risk factors enhanced with external medication adherence information and is delivered at the point of care to the healthcare provider and patient.

Trial Locations (1)

55425

HealthPartners Care System, Bloomington

All Listed Sponsors

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

HealthPartners Institute

OTHER

NCT03748420 - Medication Adherence Clinical Decision Support | Biotech Hunter | Biotech Hunter